Antibody light chain variable domains and their biophysically improved versions for human immunotherapy. - Wikidata - wikimedia - TriplyDB

Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.

Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.

http://www.wikidata.org/entity/Q37593692

about

An update on antibody-based immunotherapies for Clostridium difficile infection Specific in vivo knockdown of protein function by intrabodies Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies.Single-domain antibodies for biomedical applications.Immune TB Antibody Phage Display Library as a Tool To Study B Cell Immunity in TB Infections.Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human VH/VL Single-Domain Antibodies from In Vitro Display Libraries.Evaluation of strategies to control Fab light chain dimer during mammalian expression and purification: A universal one-step process for purification of correctly assembled Fab.

P2860

Q26740788-AA62DC90-3A45-45BD-90E7-209EEB06A96B Q26801077-47DC6F02-70C3-4474-B6CF-CB1E5523BD25 Q36130672-FB749AF7-BF47-4A21-8F80-8149E4C2C418 Q38628712-A72277A6-66D4-4178-A2D9-C81B640B7211 Q40061100-550A1321-E315-451B-8C5D-F1A7803C0099 Q47831558-2543C0EC-E3F8-4FCC-9629-30AA7D73D9F6 Q49358130-E99720D3-C976-4BF0-AA3D-28D59D1078E2 Q51014968-C7669C7A-9852-498F-BE23-73ED230C98BA

P2860

Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.

http://www.wikidata.org/entity/Q37593692

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antibody light chain variable ...... sions for human immunotherapy.

@en

Antibody light chain variable ...... sions for human immunotherapy.

@nl

type

label

Antibody light chain variable ...... sions for human immunotherapy.

@en

Antibody light chain variable ...... sions for human immunotherapy.

@nl

prefLabel

Antibody light chain variable ...... sions for human immunotherapy.

@en

Antibody light chain variable ...... sions for human immunotherapy.

@nl

P1433

Q37593692-BF3ECF18-F502-49C0-842C-6FE5E0945170

P1476

Q37593692-5586E01C-A048-4C20-A13A-FC4670D5A1C1

P2093

Q37593692-0456BAF0-C7BB-4344-95E9-289E3750D330

Q37593692-0F7174EC-058F-46E9-9F4B-EB765B885002

Q37593692-4BFEA45C-EF6A-46EE-8C05-99ABAF32AAD7

Q37593692-5C3C4330-4BB9-443F-A6A7-E09DFA9DD2C8

Q37593692-65351019-0656-481B-B11B-27ECE8459126

Q37593692-6F646C49-FDA8-4391-A8EB-BE3947B53616

Q37593692-8DB06533-AAAF-4FA0-8F59-2F1F1A68BE2F

Q37593692-965097C2-BF73-4481-B88C-34D16276E569

Q37593692-A3A65D4B-2F68-449D-9D6F-137241759A41

Q37593692-AEAF4E1D-2D14-4EF4-B54B-5458212FEF5B

P2860

Q37593692-017CAEC2-076B-4C55-9831-7FF17A7E1A16

Q37593692-055E8C05-7243-4615-8D72-AEF6709A62F2

Q37593692-0CE0B2BB-76DB-42EB-ACE2-D054C0329EFB

Q37593692-0FCA3E62-ADDE-4B33-826F-36B0469CC4CE

Q37593692-139619E0-13B6-47DD-B9D8-F79148D42389

Q37593692-18341C32-594F-4733-8770-9326EA6E8D8A

Q37593692-1CE9093E-C469-4A3F-BED3-EDE44FED0E53

Q37593692-1E295968-86DE-4720-BCD9-DF8E7A1A6B7F

Q37593692-22995595-C856-4D06-B050-7208990A59DB

Q37593692-27B536CF-7540-4301-8FA9-2C40F138507A

P304

Q37593692-91A1A2D1-2DE1-41F2-A99D-7A9A7BD53D67

P31

Q37593692-675872A4-34A5-43EA-BFA7-EE03C0C2C6D8

P356

Q37593692-449618E5-95A5-4115-843B-D01FF00F9142

P433

Q37593692-8E966324-920D-4D4C-B57D-D86AF055886C

P478

Q37593692-9F14C78D-84C6-4872-8CDE-9D3162528366

P577

Q37593692-E806C3F6-CA8D-4877-B845-34C7A5FFDF18

P5875

Q37593692-9891F41A-276D-4AF9-B2D6-6D8D90BAAB49

P698

Q37593692-1305C16C-7090-40CD-8B67-F52A6A0E2392

P921

Q37593692-0CFF10FB-CF6D-411F-A02B-5FEAE3A097BE

Q37593692-60E10A75-6E29-44AD-B010-D6674DD86623

P932

Q37593692-339EB785-9D87-4479-9EAD-B7B68042C04E

P356

P1433

Monoclonal Antibodies

P1476

Antibody light chain variable ...... sions for human immunotherapy.

@en

P2093

Dae Young Kim

http://www.w3.org/2001/XMLSchema#string

Henk van Faassen

http://www.w3.org/2001/XMLSchema#string

Hiba Kandalaft

http://www.w3.org/2001/XMLSchema#string

Jamshid Tanha

http://www.w3.org/2001/XMLSchema#string

John F Kelly

http://www.w3.org/2001/XMLSchema#string

Joseph D Schrag

http://www.w3.org/2001/XMLSchema#string

Mary Hefford

http://www.w3.org/2001/XMLSchema#string

Nadereh St-Amant

http://www.w3.org/2001/XMLSchema#string

Rebecca To

http://www.w3.org/2001/XMLSchema#string

Roger MacKenzie

http://www.w3.org/2001/XMLSchema#string

P2860

Enhancement of polymeric immunoglobulin receptor transcytosis by biparatopic VHH

Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity

Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins

Exploring the Capacity of Minimalist Protein Interfaces: Interface Energetics and Affinity Maturation to Picomolar KD of a Single-domain Antibody with a Flat Paratope

General strategy for the generation of human antibody variable domains with increased aggregation resistance

A disulfide-free single-domain V(L) intrabody with blocking activity towards huntingtin reveals a novel mode of epitope recognition

Crystal Structure of a Human Single Domain Antibody Dimer Formed through VH-VH Non-Covalent Interactions

Design of synthetic autonomous VH domain libraries and structural analysis of a VH domain bound to vascular endothelial growth factor

Domain antibodies: proteins for therapy

The immunoglobulin fold. Structural classification, sequence patterns and common core

P304

219-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/MABS.26844

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259723888

http://www.w3.org/2001/XMLSchema#string

P698

24423624

http://www.w3.org/2001/XMLSchema#string

P921

P932

3929445

http://www.w3.org/2001/XMLSchema#string